Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL
Clinical trial NCT00072007 · COMPLETED
Trial details
- NCT number
- NCT00072007
- Sponsor
- Swiss Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-06-01
- Primary completion
- 2003-03-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.